Literature DB >> 9282934

Roles for protein kinase C and mitogen-activated protein kinase in nicotine-induced secretion from bovine adrenal chromaffin cells.

M E Cox1, S J Parsons.   

Abstract

Both the Ca2+/phospholipid-dependent protein kinases (protein kinases C, PKCs) and mitogen-activated protein kinases (MAPKs) have been implicated as participants in the secretory response of bovine adrenomedullary chromaffin cells. To investigate a possible role for these kinases in exocytosis and the relationship of these kinases to one another, intact chromaffin cells were treated with agents that inhibited each of the kinases and analyzed for catecholamine release and MAPK/extracellular signal-regulated kinase (ERK) kinase (MEK)/MAPK activation after stimulation with secretagogues of differential efficacy. Of the three secretagogues tested, inactivation of PKCs by long-term phorbol 12-myristate 13-acetate (PMA) treatment or incubation with GF109203X had the greatest inhibitory effect on nicotine-induced catecholamine release and MEK/MAPK activation, a moderate effect on KCl-induced events, and little, if any, effect on Ca2+ ionophore-elicited exocytosis and MEK/MAPK activation. These results indicate that PKC plays a significant role in events induced by the optimal secretagogue nicotine and a lesser role in exocytosis elicited by the suboptimal secretagogues KCl and Ca2+ ionophore. Treatment of cells with the MEK-activation inhibitor PD098059 completely inhibited MEK/MAPK activation (IC50 1-5 microM) and partially inhibited catecholamine release induced by all secretagogues. However, PD098059 was more effective at inhibiting exocytosis induced by suboptimal secretagogues (IC50 approximately 10 microM) than that induced by nicotine (IC50 approximately 30 microM). These results suggest a more prominent role for MEK/MAPK in basic secretory events activated by suboptimal secretagogues than in those activated by the optimal secretagogue nicotine. However, PD098059 also partially blocked secretion potentiated by short-term PMA treatment, suggesting that PKC can function in part by signaling through MEK/MAPK to enhance secretion. Taken together, these results provide evidence for the preferential involvement of MEK/MAPK in basic secretory events activated by the suboptimal secretagogues KCl and Ca2+ ionophore and the participation of both PKC and MEK/MAPK in optimal, secretion induced by nicotine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9282934     DOI: 10.1046/j.1471-4159.1997.69031119.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

Review 1.  The regulation of neurotransmitter secretion by protein kinase C.

Authors:  P F Vaughan; J H Walker; C Peers
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

Review 2.  CXC chemokine receptors in the central nervous system: Role in cerebellar neuromodulation and development.

Authors:  Davide Ragozzino
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

3.  Involvement of protein kinase C in the presynaptic nicotinic modulation of [(3)H]-dopamine release from rat striatal synaptosomes..

Authors:  L Soliakov; S Wonnacott
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

4.  Mitochondria regulate the Ca(2+)-exocytosis relationship of bovine adrenal chromaffin cells.

Authors:  D R Giovannucci; M D Hlubek; E L Stuenkel
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

5.  Immunostimulation by the synthetic lipopeptide P3CSK4: TLR4-independent activation of the ERK1/2 signal transduction pathway in macrophages.

Authors:  M R Müller; S D Pfannes; M Ayoub; P Hoffmann; W G Bessler; K Mittenbühler
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

6.  Stimulatory effect of nobiletin, a citrus polymethoxy flavone, on catecholamine synthesis through Ser19 and Ser40 phosphorylation of tyrosine hydroxylase in cultured bovine adrenal medullary cells.

Authors:  Han Zhang; Nobuyuki Yanagihara; Yumiko Toyohira; Keita Takahashi; Hirohide Inagaki; Noriaki Satoh; Xiaoja Li; Xiumei Goa; Masato Tsutsui; Kojiro Takahaishi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-09-17       Impact factor: 3.000

Review 7.  Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system.

Authors:  Jian-xin Shen; Jerrel L Yakel
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

8.  Pyroglutamate-amyloid-β and glutaminyl cyclase are colocalized with amyloid-β in secretory vesicles and undergo activity-dependent, regulated secretion.

Authors:  Holger Cynis; Lydiane Funkelstein; Thomas Toneff; Charles Mosier; Michael Ziegler; Birgit Koch; Hans-Ulrich Demuth; Vivian Hook
Journal:  Neurodegener Dis       Date:  2014-06-18       Impact factor: 2.977

Review 9.  Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.

Authors:  Makoto Hashimoto; Eliezer Masliah
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

10.  Control of lytic function by mitogen-activated protein kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: identification of perforin and granzyme B mobilization by functional ERK2.

Authors:  S Wei; A M Gamero; J H Liu; A A Daulton; N I Valkov; J A Trapani; A C Larner; M J Weber; J Y Djeu
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.